China NMPA Product Recall - Hemolysin for blood cell analysis
China NMPA product recall for Hemolysin for blood cell analysis by Mindray Nanjing Biotechnology Co., Ltd. published August 28, 2017. Recall level: Level 3 Recall. Mindray Nanjing Biotechnology Co., Ltd. initiated a Class III voluntary recall of various hemolysing
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA product recall for Hemolysin for blood cell analysis by Mindray Nanjing Biotechnology Co., Ltd. published August 28, 2017. Recall level: Level 3 Recall. Mindray Nanjing Biotechnology Co., Ltd. initiated a Class III voluntary recall of various hemolysing
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox